Lantern Pharma (LTRN) Live Share Price, Invest From India

Lantern Pharma Stock Performance

as on October 24, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.59
Day's Price Range
$0.66
$0.64
7.15%
Downside
3.87%
Upside
52 Week's Low
52 Week's High
$0.59
52-Week Price Range
$4.34
$0.64
6.99%
Downside
583.03%
Upside

Lantern Pharma share price movements today

Previous Close: $0.64
Open: $0.66
Volume: 1.4M
Market Cap: $9.6M
Day's Low - High: $0.59 - $0.66
52 Week Low - High: $0.59 - $4.34

Lantern Pharma Historical Returns

1 Month Return: -47.49 %
3 Month Return: -76.89 %
1 Year Return: -84.43 %
3 Year Return: -77.63 %
5 Year Return: -93.7 %

Lantern Pharma Stock Fundamentals & Key Indicators

Check Lantern Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.6M

EPS (TTM)

-1.62

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.4

Industry PE ratio

-3.17

PEG Ratio

-0.06

EBITDA

-18.6M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-456.35%

Lantern Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lantern Pharma with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Lantern Pharma	Buy	$9.6M	-93.70%	-0.40	0.00%	0.00%
Moderna	Neutral	$80.9B	-38.72%	-25.39	-12.57%	0.00%
BeOne Medicines	StrongBuy	$43.5B	NA	26.46	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$135.6B	185.49%	30.90	86.04%	0.00%
Regeneron	Buy	$83.1B	40.65%	19.56	84.86%	0.46%

Stock Returns calculator for Lantern Pharma Stock including INR - Dollar returns

The Lantern Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Lantern Pharma investment value today

Current value as on today

₹16,833

Returns

-₹83,167

(-83.17%)

Returns from Lantern Pharma Stock

-₹84,426 (-84.43%)

Dollar Impact

₹1,260 (+1.26%)

Analyst Recommendation on Lantern Pharma Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Lantern Pharma. Average target price of $17.5

Lantern Pharma Share Price Target

Get share price movements and forecasts by analysts on Lantern Pharma.

What analysts predicted

96.37%UPSIDE

Target Price

$17.5

Current Price

$0.6354

Analyzed by

8 Analysts

Target

$17.50

Lantern Pharma target price $17.5, a slight upside of 96.37% compared to current price of $0.6354. According to 8 analysts rating.

Indian Investors' Interest in Lantern Pharma Stock

Search interest for Lantern Pharma Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 25, 2026 to October 25, 2026

Change:-28% versus previous 30 day period

Lantern Pharma Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	0	-
Operating Income	-5	-5	-5	-5	-4	-4	-4	-4	-3	-3
EBITDA	-5	-4	-4	-5	-4	-4	-4	-4	-3	-7
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-4	-4	-5	-4	-4	-4	-4	-3	-7
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-4	-4	-5	-4	-4	-4	-4	-3	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lantern Pharma Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	-	-	-	0	-	-
Operating Income	-1	-2	-5	-12	-14,432	-17	-22	-17
EBITDA	-1	-2	-5	-12	-14,259	-15	-20	-17
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-5	-12	-14,259	-15	-20	-17
Income Tax Expense	0	-	-	-	-	-	-	-
Net Income	-1	-2	-5	-12	-14,259	-15	-20	-17
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lantern Pharma Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-5	-4	-4	-5	-4	-4	-4	-4	-3	-7
Operating Cash Flow	-3	-5	-5	-3	-4	-3	-4	-2	-3	-2
Investing Cash Flow	0	0	0	3	3	3	5	-1	4	0
Financing Cash Flow	0	-	0	-	-	-	0	0	-	3
Change in Cash	-3	-5	-4	0	-1	0	2	-3	0	1

Lantern Pharma Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-2	-5	-12	-14	-15	-20	-17
Operating Cash Flow	-1	-2	-5	-10	-12	-14	-17	-15
Investing Cash Flow	0	0	0	-19	0	0	3	11
Financing Cash Flow	0	2	23	63	-2	0	0	1
Change in Cash	0	0	17	33	-14	-15	-14	-3

Global Institutional Holdings in Lantern Pharma

Check out the Institutions with significant holdings in Lantern Pharma.

Funds	Holdings
Vanguard	2.81%
VANGUARD INDEX FUNDS	2.22%
Fidelity Concord Street Trust	0.53%
Horizon Kinetics	0.15%
DFA INVESTMENT DIMENSIONS GROUP INC	0.06%

See all

Insights on Lantern Pharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 160.7% return, outperforming this stock by 238.2%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 648.3% return, outperforming this stock by 732.7%
NEGATIVE IMPACT
Price Dip
In the last 1 month, LTRN stock has moved down by -47.9%

About Lantern Pharma

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.

Organisation	Lantern Pharma
Headquarters	1920 McKinney Avenue, Dallas, TX, 75201, US
Industry	Biotechnology
CEO	Panna Sharma

Key Management of Lantern Pharma

Name	Title
Mr. Panna Sharma	President, CEO & Director
Mr. David R. Margrave	CFO & Secretary
Dr. Kishor Gopaldas Bhatia Ph.D.	Chief Scientific Officer & Scientific Consultant
Dr. Peter L. Nara D.V.M., M.S., Ph.D.	Co-Founder & Advisor
Dr. Marc C. Chamberlain M.D.	Chief Medical Officer of Starlight Therapeutics

FAQs

What is Lantern Pharma share price today?

Lantern Pharma share price today is $0.64 as on October 24, 2026 at 8:46 am IST at the close of the market. Lantern Pharma share today touched a day high of $0.66 and a low of $0.59.

What is the 52 week high and 52 week low for Lantern Pharma share?

Lantern Pharma share touched a 52 week high of $4.34 on July 1, 2026 and a 52 week low of $0.59 on October 23, 2026. Lantern Pharma stock price today i.e. October 24, 2026 at 8:46 am IST is closed at $0.64,which is 85.36% down from its 52 week high and 7.51% up from its 52 week low.

What is Lantern Pharma's market capitalisation today?

Lantern Pharma market capitalisation is $0.00T as on October 24, 2026 at 8:46 am IST.

How to invest in Lantern Pharma Stock (LTRN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lantern Pharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lantern Pharma Stock (LTRN) from India?

Indian investors can start investing in Lantern Pharma (LTRN) shares with as little as ₹94.94000244140625 or $1 (as of October 25, 2026 at 9:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Lantern Pharma stock (as per the Rupee-Dollar exchange rate as on October 25, 2026 at 9:36 am IST). Based on Lantern Pharma share’s latest price of $0.64 as on October 24, 2026 at 8:46 am IST, you will get 15.7381 shares of Lantern Pharma. Learn more about fractional shares .

What are the returns that Lantern Pharma has given to Indian investors in the last 5 years?

Lantern Pharma stock has given -93.7% share price returns and 25.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?